Novel opioid antagonists for opioid-induced bowel dysfunction

By Diego Laura   Atayee Rabia   Helmons Pieter   Hsiao Grace   von Gunten Charles F  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1047-1056

Informa Healthcare

Access to resources Recommend Favorite

Opioid-Induced Bowel Dysfunction: Pathophysiology and Management

By Brock Christina   >   >   Frøkjaer Jens Brøndum   Andresen Trine   >  

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1847-1865

Adis International

Access to resources Recommend Favorite

Opioid-Induced Bowel Dysfunction: Pathophysiology and Potential New Therapies

By Kurz A.  

Drugs, Vol. 63, Iss. 7, 2003-01 ,pp. : 649-671

Adis International

Access to resources Recommend Favorite

Oxycodone/Naloxone in the Management of Patients with Pain and Opioid–Induced Bowel Dysfunction

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 124-135

Bentham Science Publishers

Access to resources Recommend Favorite

Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain

By Clemens Katri Elina   Mikus Gerd  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 297-310

Informa Healthcare

Access to resources Recommend Favorite